ORIGINAL RESEARCH article
Front. Vet. Sci.
Sec. Comparative and Clinical Medicine
Volume 12 - 2025 | doi: 10.3389/fvets.2025.1634940
The Effect of Dietary Tryptophan Supplementation, and An Oral Tryptophan Challenge, on Urinary Excretion of 5-hydroxyindoleacetic Acid in Domestic Dogs
Provisionally accepted- 1University Veterinary Teaching Hospital Sydney, Camperdown, Australia
- 2Veterinary Clinical Science, Oregon State University, Corvallis, Oregon, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Chronic enteropathies, commonly referred to as inflammatory bowel disease, are multifactorial disorders that affect a substantial proportion of both the human population and companion animals. There is an emerging body of evidence suggesting that alterations in serotonin metabolism may contribute to the development of inflammatory bowel disease in humans. 5-Hydroxyindole acetic acid (5-HIAA) is a major metabolite of serotonin which undergoes renal excretion, providing a non-invasive indicator of serotonin metabolism. This study validated a commercial ELISA assay for 5-HIAA for use in canines and investigated the effect of dietary tryptophan supplementation and tryptophan challenge on the excretion of 5-HIAA in healthy dogs (n = 14). Dietary supplementation was associated with sustained alterations in serotonin metabolism, whereas a short-term oral tryptophan challenge, did not significantly impact immediate 5-HIAA excretion at 4-and 8-hours post-challenge. These findings provide key insights regarding potential confounding factors for the interpretation of urinary 5-HIAA secretion as a marker of serotonin metabolism in domestic animals. Future prospective studies with a larger sample size are required to compare the serotonin concentrations between dogs with chronic enteropathy and healthy dogs on the tryptophan loading/challenge tests.
Keywords: Serotonin, Tryptophan, Chronic enteropathy, inflammatory bowel disease, 5-hydroxyindoleacetic acid
Received: 25 May 2025; Accepted: 17 Sep 2025.
Copyright: © 2025 Cheung, Rigling, Stang and Ruaux. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Chloe Cheung, chloe.cheung@sydney.edu.au
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.